These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 86269)

  • 1. [Polish hydroxyethyl starch preparation: a clinical study].
    Schier J; Kościelak J; Szczepanik A; Gryszkiewicz A; Lopaciuk S; Konopka L; Rudowski W
    Acta Haematol Pol; 1979; 10(1):51-8. PubMed ID: 86269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experiences with a 6% hydroxyethyl starch 40000 solution; metabolic parameters and tolerance].
    Kori-Lindner C; Hubert H
    Infusionsther Klin Ernahr; 1978 Apr; 5(2):93-8. PubMed ID: 77256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Using solutions of hydroxyethyl starch (6% HES 200/0.5 (refortan) and 6% HES 130/0.4 (voluven)) in neuroanesthesiology].
    Kondrat'ev AN; Novikov VIu; Savvina IA; Driagina NV
    Anesteziol Reanimatol; 2008; (2):27-30. PubMed ID: 18543426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
    Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
    J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improvement of the flow properties of the blood of patients by low-molecular hydroxyethyl starch (Expafusin)].
    Landgraf H; Ruppel C; Saeger-Lorenz K; Vogel C; Ehrly AM
    Infusionsther Klin Ernahr; 1982 Aug; 9(4):202-6. PubMed ID: 6182099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular effects of rapid fluid infusion during anesthesia].
    Iwasawa H
    Masui; 1987 Sep; 36(9):1414-21. PubMed ID: 2447301
    [No Abstract]   [Full Text] [Related]  

  • 8. [The influence of isovolaemic haemodilution using hydroxyethyl starch on cardiovascular and other organ functions during vascular surgery (author's transl)].
    Watzek C; Wagner O; Draxler V; Gilly H; Schwarz S; Sporn P; Steinbereithner K; Zekert F; Gerwin V; Leonhartsberger I; Matejcek E; Sailer E; Wiche E
    Wien Klin Wochenschr; 1978 Mar; 90(7):224-33. PubMed ID: 76369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
    Penner M; Fingerhut D; Tacke A
    Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
    Mishler JM
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of hemodilution with plasma protein solution and hydroxyethyl starch on plasma fibronectin].
    Khosropour R; Graninger W; Lackner F
    Anasth Intensivther Notfallmed; 1984 Aug; 19(4):175-8. PubMed ID: 6208807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
    Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
    Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
    Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
    Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
    London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
    J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in blood coagulation in treatment with hydroxyethyl starch].
    Sefrin P; Rauch S; Zieglmeyer C
    Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a hydroxyethylstarch solution on plasma colloid osmotic pressure in acutely ill patients.
    Mbaba Mena J; De Backer D; Vincent JL
    Acta Anaesthesiol Belg; 2000; 51(1):39-42. PubMed ID: 10806521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
    Hopf HB; Siepmann HP
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfusion therapy of traumatic shock using plasma substitutes oxyamal and volecam].
    Kardovskiĭ AG; Bugrova KP; Guzhov MN; Kosacheva KA
    Vestn Khir Im I I Grek; 1990 Apr; 144(4):74-8. PubMed ID: 1700532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.